Phoenix Healthcare, a division of Phoenix Marketing International, has appointed Andrew Scott as Managing Director – Europe, responsible for sales as well as conducting global quant and qual studies for multinational biopharma clients.
Scott joins with more than 25 years’ market research experience. Most recently, he was MD of Kantar Health-owned Ziment – Europe, where he worked directly with pharma clients on new product development and global product launches across multiple therapeutic areas. He has also worked in senior positions at NOP Healthcare (now GfK).
‘Andrew is a very talented hands-on researcher who thoroughly understands clients’ business issues and has proven his dedication to both his team and his clients throughout his career,’ states David Luery, EVP of Phoenix Healthcare and MD of the International Division. ‘He has achieved great success throughout his career and we look forward to his contribution and growing role within the team.’
Phoenix Healthcare, a division of Phoenix Marketing International, has appointed Andrew Scott as Managing Director – Europe, responsible for sales as well as conducting global quant and qual studies for multinational biopharma clients.